Position in TKNO
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$3,089,878
+$1,974,290 QoQ
Shares Held
1,069,162
+264.2% QoQ
Ownership
1.99%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TKNO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026ROYCE & ASSOCIATES LP holds $70,326,489 across 14 Drug Manufacturers - Specialty & Generic names. TKNO ranks #8 (4.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SUPN |
Supernus Pharmaceuticals, Inc.
|
229,939 | $11,885,546 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
469,916 | $11,245,089 | |
| 3 | PBH |
Prestige Consumer Healthcare Inc.
|
157,126 | $9,312,858 | |
| 4 | COLL |
Collegium Pharmaceutical, Inc
|
272,786 | $9,021,033 | |
| 5 | AMPH |
Amphastar Pharmaceuticals, Inc.
|
406,175 | $7,956,968 | |
| 6 | ESPR |
Esperion Therapeutics, Inc.
|
2,626,995 | $7,197,966 | |
| 7 | SIGA |
Siga Technologies Inc
|
667,646 | $3,571,906 | |
| 8 | TKNO |
Alpha Teknova, Inc.
This page
|
1,069,162 | $3,089,878 |
All Filings in TKNO
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,089,878 | 1,069,162 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $1,115,588 | 293,576 | Shares | Sole | 2026-02-09 | |
| No filing history on record for this holder in this stock. | ||||||